08
Sep
Boom in unproven cell therapies intensifies regulatory debate
Boom in unproven cell therapies intensifies regulatory debate Steve Gschmeissner/SPL Thomas Albini met his first patient blinded by a stem-cell ‘treatment’ last year. The elderly woman, who had macular degeneration, thought she was paying to participate in a clinical trial…
Read More